Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

127.9800 USD 1.2200 0.94%

As of 20:04:04 ET on 02/27/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 128.9800 High - Low: 129.3000 - 127.4700 Primary Exchange: NYSE Arca
Volume: 133,086 52-Week Range: 80.0500 - 129.6900 Beta vs MVBBHTR: 1.0007

ETF Chart for BBH

No chart data available.
  • BBH:US 127.9800
  • 1D
  • 1M
  • 1Y
129.2000
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-02-27) 127.9426
Assets (M) (on 2015-02-27) 735.2222
Shares out (M) 5.75
Market Cap (M) 735.44
% Premium 0.03
Average 52-Week % Premium -0.0068
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) -%

Performance for BBH

1-Month +4.04% 1-Year +25.10%
3-Month +9.30% 3-Year +44.99%
Year To Date +10.92% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 02/26/2015
Name Position Value % of Total
Gilead Sciences Inc 942,576 98,206,993 13.233%
Amgen Inc 523,461 83,214,595 11.213%
Celgene Corp 636,419 78,502,284 10.578%
Biogen Idec Inc 143,267 58,753,797 7.917%
BioMarin Pharmaceutical Inc 337,216 36,702,589 4.945%
Illumina Inc 167,636 33,269,041 4.483%
Alexion Pharmaceuticals Inc 178,887 32,755,999 4.414%
Incyte Corp 369,852 32,376,844 4.363%
Pharmacyclics Inc 146,291 31,865,106 4.294%
Vertex Pharmaceuticals Inc 262,983 31,550,071 4.251%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil